The UK Medical Cannabis & Cannabinoid Regulation Guide 2025 includes analysis of trends and developments in this quickly-developing area of law. In this publication, co-authors Cameron Crowe KC and Robin Kingham discuss the difficulties posed by uncertainties in the law and changes in governmental approaches.
The publication examines the uncertain legal framework for Medical Cannabis and CBD in the UK including:
- Licensing rules for medical cannabis
- The status of CBD products under the novel foods regime
- Unresolved questions surrounding THC Limits under the Misuse of Drugs Regulations 2001
- Recent regulatory developments and their implications since Brexit
The Guide can be accessed via the Chambers and Partners website, linked here.
Cameron Crowe KC and Robin Kingham are both ranked as leading practitioners in Life Sciences Regulation. To read more about their specialisms, please click on the profiles below.
